AIA Group Ltd Has $4.54 Million Stock Holdings in Centene Corporation $CNC

AIA Group Ltd boosted its position in shares of Centene Corporation (NYSE:CNC) by 102.5% during the 3rd quarter, HoldingsChannel reports. The fund owned 127,367 shares of the company’s stock after buying an additional 64,475 shares during the quarter. AIA Group Ltd’s holdings in Centene were worth $4,544,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds also recently modified their holdings of the company. Baird Financial Group Inc. bought a new stake in Centene in the 1st quarter valued at $236,000. Sivia Capital Partners LLC lifted its holdings in shares of Centene by 80.0% during the 2nd quarter. Sivia Capital Partners LLC now owns 9,710 shares of the company’s stock worth $527,000 after acquiring an additional 4,315 shares during the period. Creative Planning boosted its position in shares of Centene by 68.2% during the 2nd quarter. Creative Planning now owns 78,451 shares of the company’s stock valued at $4,258,000 after acquiring an additional 31,797 shares in the last quarter. Citizens Financial Group Inc. RI bought a new stake in Centene in the second quarter valued at about $303,000. Finally, Rockefeller Capital Management L.P. raised its position in Centene by 71.0% in the second quarter. Rockefeller Capital Management L.P. now owns 22,903 shares of the company’s stock worth $1,243,000 after purchasing an additional 9,506 shares in the last quarter. Institutional investors own 93.63% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on CNC shares. Robert W. Baird lifted their price objective on Centene from $28.00 to $36.00 and gave the company a “neutral” rating in a report on Thursday, December 11th. Sanford C. Bernstein restated an “outperform” rating and set a $59.00 target price on shares of Centene in a research report on Tuesday, January 6th. Wall Street Zen lowered Centene from a “buy” rating to a “hold” rating in a research note on Sunday, February 15th. JPMorgan Chase & Co. dropped their price objective on Centene from $45.00 to $41.00 and set a “neutral” rating for the company in a research note on Thursday. Finally, Weiss Ratings reissued a “sell (d)” rating on shares of Centene in a report on Wednesday, January 21st. Three investment analysts have rated the stock with a Buy rating, fourteen have assigned a Hold rating and three have issued a Sell rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $41.81.

Centene Stock Down 1.6%

Shares of CNC opened at $35.57 on Friday. The company has a market capitalization of $17.49 billion, a P/E ratio of -2.61, a PEG ratio of 0.80 and a beta of 0.48. Centene Corporation has a one year low of $25.08 and a one year high of $66.03. The business’s 50 day simple moving average is $41.98 and its 200-day simple moving average is $38.51. The company has a debt-to-equity ratio of 0.87, a current ratio of 1.10 and a quick ratio of 1.10.

Centene (NYSE:CNC) last released its quarterly earnings results on Friday, February 6th. The company reported ($1.19) earnings per share for the quarter, beating analysts’ consensus estimates of ($1.22) by $0.03. The firm had revenue of $49.73 billion during the quarter, compared to analysts’ expectations of $48.41 billion. Centene had a positive return on equity of 4.25% and a negative net margin of 3.43%.The business’s revenue was up 21.9% on a year-over-year basis. During the same period last year, the firm posted $0.80 EPS. Centene has set its FY 2026 guidance at 3.000-3.000 EPS. As a group, sell-side analysts predict that Centene Corporation will post 6.86 EPS for the current fiscal year.

About Centene

Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.